UK Buyers Club To Get Lower Cost Versions Of Vertex’s CF Drugs

 
• By Francesca Bruce
  
Generate a summary of this article
Listen to this article
Beta

A buyers club in the UK is planning to import generic versions of Vertex’s cystic fibrosis drugs that are not available on the NHS.  Some commentators think such clubs may become more common.

CysticFibrosis
UK Buyers Club Aims To Access Generic Versions Of Orkambi For CF

The Cystic Fibrosis Buyers Club, set up in the UK by parents of children with the condition, is hoping to help some patients import generic versions of Vertex’s cystic fibrosis drug Orkambi (ivacaftor/lumacaftor) from Latin America. Health advocates hope the move could lead to a compulsory license for Orkambi and believe that buyers clubs could be used more frequently in response to medicine prices that prohibit access to medicines.

Three years after UK health technology assessment body NICE initially rejected Orkambi, claiming that £105,000 was too high a price...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

EU Biosimilar Filings, Opinions And Approvals

 
• By Saba Afreen

<p>Executive Summary</p> <p>A list of EU biosimilar filings, CHMP opinions and EU marketing authorizations, including details of the biosimilar company, the brand name/INN, indication(s), the reference product/company, and the date and type of event.</p>

EU Pharma Reform: What You Need to Know Now

 
• By Anabel Costa-Ferreira and Ian Schofield

As the reform of the EU pharmaceutical legislation progresses through the legislative process, the Pinks Sheet offers an infographic highlighting some of the key changes being proposed that will reshape the way drug companies run their business.

New EU Approvals

<p>Executive Summary<p> <p>The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add six new products, incl/ding Ixchiq, Valneva's chikungunya virus vaccine</p>

More from Geography

Canada Cuts Red Tape With Single Ethics Review For Trials

A new research ethics review system for multi-site clinical trials in Canada is expected to help improve study start-up times, avoid unnecessary duplication and boost the country’s competitiveness on a global stage.

Nancy Test Circulable Section Geography

 
• By Brian Bossetta

This is a short description

Diversity Action Plans: What To Submit And When

 
• By Nielsen Hobbs

With the deadline for comments on the US FDA’s draft guidance less than a month away, the Pink Sheet offers an infographic outlining what the agency is expecting in diversity action plans and when that might be implemented.